APO Research
Talk to an analyst

APO RESEARCH · REPORT

Anti-inflammatory Medicine for Pets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Anti-inflammatory Medicine for Pets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025196 pages

Choose your research edition.

Industry ResearchAnti-inflammatory Medicine for Pets Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Anti-inflammatory Medicine for Pets Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Anti-inflammatory Medicine for Pets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Anti-inflammatory Medicine for Pets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Anti-inflammatory Medicine for Pets Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Anti-inflammatory Medicine for Pets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Anti-inflammatory Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Anti-inflammatory Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Anti-inflammatory Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Anti-inflammatory Medicine for Pets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Anti-inflammatory Medicine for Pets include Zoetis, Merck, Wuhan chopperlvya, Virbac, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun and Elanco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Anti-inflammatory Medicine for Pets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Anti-inflammatory Medicine for Pets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Anti-inflammatory Medicine for Pets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Anti-inflammatory Medicine for Pets market size, projected growth trends, production technologies, key applications, and end-use industries.

Anti-inflammatory Medicine for Pets Segment by Company

Zoetis

Merck

Wuhan chopperlvya

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Elanco

Dechra Veterinary Products

Ceva

CAHIC

Boehringer Ingelheim

Anti-inflammatory Medicine for Pets Segment by Type

Powder

Liquid

Anti-inflammatory Medicine for Pets Segment by Application

Reptile

Cat

Dog

Other

Anti-inflammatory Medicine for Pets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-inflammatory Medicine for Pets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Anti-inflammatory Medicine for Pets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-inflammatory Medicine for Pets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Anti-inflammatory Medicine for Pets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Anti-inflammatory Medicine for Pets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Anti-inflammatory Medicine for Pets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Anti-inflammatory Medicine for Pets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Anti-inflammatory Medicine for Pets Industry Trends Table 2. Anti-inflammatory Medicine for Pets Industry Drivers Table 3. Anti-inflammatory Medicine for Pets Industry Opportunities and Challenges Table 4. Anti-inflammatory Medicine for Pets Industry Restraints Table 5. Global Anti-inflammatory Medicine for Pets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Anti-inflammatory Medicine for Pets Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Anti-inflammatory Medicine for Pets Sales Market Share by Manufacturers Table 9. Global Anti-inflammatory Medicine for Pets Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Anti-inflammatory Medicine for Pets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Anti-inflammatory Medicine for Pets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Anti-inflammatory Medicine for Pets Manufacturers, Product Type & Application Table 13. Global Anti-inflammatory Medicine for Pets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Anti-inflammatory Medicine for Pets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Powder Table 17. Major Manufacturers of Liquid Table 18. Global Anti-inflammatory Medicine for Pets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Anti-inflammatory Medicine for Pets Sales by Type (2021-2026) & (k units) Table 20. Global Anti-inflammatory Medicine for Pets Sales by Type (2027-2032) & (k units) Table 21. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2021-2026) Table 22. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2027-2032) Table 23. Global Anti-inflammatory Medicine for Pets Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Anti-inflammatory Medicine for Pets Revenue by Type (2021-2026) & (k units) Table 25. Global Anti-inflammatory Medicine for Pets Revenue by Type (2027-2032) & (k units) Table 26. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2021-2026) Table 27. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Reptile Table 29. Major Manufacturers of Cat Table 30. Major Manufacturers of Dog Table 31. Major Manufacturers of Other Table 32. Global Anti-inflammatory Medicine for Pets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Anti-inflammatory Medicine for Pets Sales by Application (2021-2026) & (k units) Table 34. Global Anti-inflammatory Medicine for Pets Sales by Application (2027-2032) & (k units) Table 35. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2021-2026) Table 36. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2027-2032) Table 37. Global Anti-inflammatory Medicine for Pets Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Anti-inflammatory Medicine for Pets Revenue by Application (2021-2026) & (k units) Table 39. Global Anti-inflammatory Medicine for Pets Revenue by Application (2027-2032) & (k units) Table 40. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2021-2026) Table 41. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2027-2032) Table 42. Global Anti-inflammatory Medicine for Pets Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Anti-inflammatory Medicine for Pets Sales by Region (2021-2026) & (k units) Table 44. Global Anti-inflammatory Medicine for Pets Sales Market Share by Region (2021-2026) Table 45. Global Anti-inflammatory Medicine for Pets Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Anti-inflammatory Medicine for Pets Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 49. North America Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 50. Europe Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 52. Europe Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2027-2032) & (k units) Table 59. Global Anti-inflammatory Medicine for Pets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Anti-inflammatory Medicine for Pets Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Anti-inflammatory Medicine for Pets Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2021-2026) Table 63. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2027-2032) Table 64. Zoetis Company Information Table 65. Zoetis Business Overview Table 66. Zoetis Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Zoetis Anti-inflammatory Medicine for Pets Product Portfolio Table 68. Zoetis Recent Development Table 69. Merck Company Information Table 70. Merck Business Overview Table 71. Merck Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Merck Anti-inflammatory Medicine for Pets Product Portfolio Table 73. Merck Recent Development Table 74. Wuhan chopperlvya Company Information Table 75. Wuhan chopperlvya Business Overview Table 76. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio Table 78. Wuhan chopperlvya Recent Development Table 79. Virbac Company Information Table 80. Virbac Business Overview Table 81. Virbac Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Virbac Anti-inflammatory Medicine for Pets Product Portfolio Table 83. Virbac Recent Development Table 84. Vetoquinol Company Information Table 85. Vetoquinol Business Overview Table 86. Vetoquinol Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio Table 88. Vetoquinol Recent Development Table 89. Ouro Fino Saude Company Information Table 90. Ouro Fino Saude Business Overview Table 91. Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio Table 93. Ouro Fino Saude Recent Development Table 94. Norbrook Company Information Table 95. Norbrook Business Overview Table 96. Norbrook Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Norbrook Anti-inflammatory Medicine for Pets Product Portfolio Table 98. Norbrook Recent Development Table 99. Jindun Company Information Table 100. Jindun Business Overview Table 101. Jindun Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Jindun Anti-inflammatory Medicine for Pets Product Portfolio Table 103. Jindun Recent Development Table 104. Elanco Company Information Table 105. Elanco Business Overview Table 106. Elanco Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Elanco Anti-inflammatory Medicine for Pets Product Portfolio Table 108. Elanco Recent Development Table 109. Dechra Veterinary Products Company Information Table 110. Dechra Veterinary Products Business Overview Table 111. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio Table 113. Dechra Veterinary Products Recent Development Table 114. Ceva Company Information Table 115. Ceva Business Overview Table 116. Ceva Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Ceva Anti-inflammatory Medicine for Pets Product Portfolio Table 118. Ceva Recent Development Table 119. CAHIC Company Information Table 120. CAHIC Business Overview Table 121. CAHIC Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. CAHIC Anti-inflammatory Medicine for Pets Product Portfolio Table 123. CAHIC Recent Development Table 124. Boehringer Ingelheim Company Information Table 125. Boehringer Ingelheim Business Overview Table 126. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio Table 128. Boehringer Ingelheim Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Anti-inflammatory Medicine for Pets Distributors List Table 132. Anti-inflammatory Medicine for Pets Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Anti-inflammatory Medicine for Pets Product Image Figure 2. Global Anti-inflammatory Medicine for Pets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Anti-inflammatory Medicine for Pets Market Size (2021-2032) & (US$ Million) Figure 4. Global Anti-inflammatory Medicine for Pets Sales (2021-2032) & (k units) Figure 5. Global Anti-inflammatory Medicine for Pets Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Anti-inflammatory Medicine for Pets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Powder Image Figure 9. Liquid Image Figure 10. Global Anti-inflammatory Medicine for Pets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Anti-inflammatory Medicine for Pets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2021-2032) Figure 13. Global Anti-inflammatory Medicine for Pets Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Anti-inflammatory Medicine for Pets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2021-2032) Figure 16. Reptile Image Figure 17. Cat Image Figure 18. Dog Image Figure 19. Other Image Figure 20. Global Anti-inflammatory Medicine for Pets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Anti-inflammatory Medicine for Pets Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2021-2032) Figure 23. Global Anti-inflammatory Medicine for Pets Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Anti-inflammatory Medicine for Pets Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2021-2032) Figure 26. North America Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Anti-inflammatory Medicine for Pets Sales Market Share by Country (2021-2032) Figure 28. U.S. Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Anti-inflammatory Medicine for Pets Sales Market Share by Country (2021-2032) Figure 33. Germany Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Anti-inflammatory Medicine for Pets Sales Market Share by Country (2021-2032) Figure 40. China Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales Market Share by Country (2021-2032) Figure 48. Brazil Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Anti-inflammatory Medicine for Pets Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Anti-inflammatory Medicine for Pets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Figure 59. North America Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Figure 61. Europe Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Anti-inflammatory Medicine for Pets Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Anti-inflammatory Medicine for Pets Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Powder
  • Liquid
Applications
  • Reptile
  • Cat
  • Dog
  • Other
Companies covered
  • Zoetis
  • Merck
  • Wuhan chopperlvya
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Jindun
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • CAHIC
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Anti-inflammatory Medicine for Pets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Anti-inflammatory Medicine for Pets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Anti-inflammatory Medicine for Pets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Anti-inflammatory Medicine for Pets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Anti-inflammatory Medicine for Pets Market Dynamics
  1. 2.1 Anti-inflammatory Medicine for Pets Industry Trends
  2. 2.2 Anti-inflammatory Medicine for Pets Industry Drivers
  3. 2.3 Anti-inflammatory Medicine for Pets Industry Opportunities and Challenges
  4. 2.4 Anti-inflammatory Medicine for Pets Industry Restraints
3 Anti-inflammatory Medicine for Pets Market by Manufacturers
  1. 3.1 Global Anti-inflammatory Medicine for Pets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Anti-inflammatory Medicine for Pets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Anti-inflammatory Medicine for Pets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Anti-inflammatory Medicine for Pets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Anti-inflammatory Medicine for Pets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Anti-inflammatory Medicine for Pets Manufacturers, Product Type & Application
  7. 3.7 Global Anti-inflammatory Medicine for Pets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Anti-inflammatory Medicine for Pets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Anti-inflammatory Medicine for Pets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Anti-inflammatory Medicine for Pets Tier 1, Tier 2, and Tier 3
4 Anti-inflammatory Medicine for Pets Market by Type
  1. 4.1 Anti-inflammatory Medicine for Pets Type Introduction
  2. 4.1.1 Powder
  3. 4.1.2 Liquid
  4. 4.2 Global Anti-inflammatory Medicine for Pets Sales by Type
  5. 4.2.1 Global Anti-inflammatory Medicine for Pets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Anti-inflammatory Medicine for Pets Sales by Type (2021-2032)
  7. 4.2.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Anti-inflammatory Medicine for Pets Revenue by Type
  9. 4.3.1 Global Anti-inflammatory Medicine for Pets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Anti-inflammatory Medicine for Pets Revenue by Type (2021-2032)
  11. 4.3.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Type (2021-2032)
5 Anti-inflammatory Medicine for Pets Market by Application
  1. 5.1 Anti-inflammatory Medicine for Pets Application Introduction
  2. 5.1.1 Reptile
  3. 5.1.2 Cat
  4. 5.1.3 Dog
  5. 5.1.4 Other
  6. 5.2 Global Anti-inflammatory Medicine for Pets Sales by Application
  7. 5.2.1 Global Anti-inflammatory Medicine for Pets Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Anti-inflammatory Medicine for Pets Sales by Application (2021-2032)
  9. 5.2.3 Global Anti-inflammatory Medicine for Pets Sales Market Share by Application (2021-2032)
  10. 5.3 Global Anti-inflammatory Medicine for Pets Revenue by Application
  11. 5.3.1 Global Anti-inflammatory Medicine for Pets Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Anti-inflammatory Medicine for Pets Revenue by Application (2021-2032)
  13. 5.3.3 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Application (2021-2032)
6 Global Anti-inflammatory Medicine for Pets Sales by Region
  1. 6.1 Global Anti-inflammatory Medicine for Pets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Anti-inflammatory Medicine for Pets Sales by Region (2021-2032)
  3. 6.2.1 Global Anti-inflammatory Medicine for Pets Sales by Region (2021-2026)
  4. 6.2.2 Global Anti-inflammatory Medicine for Pets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Anti-inflammatory Medicine for Pets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Anti-inflammatory Medicine for Pets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Anti-inflammatory Medicine for Pets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Anti-inflammatory Medicine for Pets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Anti-inflammatory Medicine for Pets Revenue by Region
  1. 7.1 Global Anti-inflammatory Medicine for Pets Revenue by Region
  2. 7.1.1 Global Anti-inflammatory Medicine for Pets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Anti-inflammatory Medicine for Pets Revenue by Region (2021-2026)
  4. 7.1.3 Global Anti-inflammatory Medicine for Pets Revenue by Region (2027-2032)
  5. 7.1.4 Global Anti-inflammatory Medicine for Pets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Anti-inflammatory Medicine for Pets Revenue (2021-2032)
  8. 7.2.2 North America Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Anti-inflammatory Medicine for Pets Revenue (2021-2032)
  11. 7.3.2 Europe Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Anti-inflammatory Medicine for Pets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Anti-inflammatory Medicine for Pets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Anti-inflammatory Medicine for Pets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Anti-inflammatory Medicine for Pets Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Anti-inflammatory Medicine for Pets Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 Wuhan chopperlvya
  14. 8.3.1 Wuhan chopperlvya Company Information
  15. 8.3.2 Wuhan chopperlvya Business Overview
  16. 8.3.3 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wuhan chopperlvya Anti-inflammatory Medicine for Pets Product Portfolio
  18. 8.3.5 Wuhan chopperlvya Recent Developments
  19. 8.4 Virbac
  20. 8.4.1 Virbac Company Information
  21. 8.4.2 Virbac Business Overview
  22. 8.4.3 Virbac Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Virbac Anti-inflammatory Medicine for Pets Product Portfolio
  24. 8.4.5 Virbac Recent Developments
  25. 8.5 Vetoquinol
  26. 8.5.1 Vetoquinol Company Information
  27. 8.5.2 Vetoquinol Business Overview
  28. 8.5.3 Vetoquinol Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vetoquinol Anti-inflammatory Medicine for Pets Product Portfolio
  30. 8.5.5 Vetoquinol Recent Developments
  31. 8.6 Ouro Fino Saude
  32. 8.6.1 Ouro Fino Saude Company Information
  33. 8.6.2 Ouro Fino Saude Business Overview
  34. 8.6.3 Ouro Fino Saude Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Ouro Fino Saude Anti-inflammatory Medicine for Pets Product Portfolio
  36. 8.6.5 Ouro Fino Saude Recent Developments
  37. 8.7 Norbrook
  38. 8.7.1 Norbrook Company Information
  39. 8.7.2 Norbrook Business Overview
  40. 8.7.3 Norbrook Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Norbrook Anti-inflammatory Medicine for Pets Product Portfolio
  42. 8.7.5 Norbrook Recent Developments
  43. 8.8 Jindun
  44. 8.8.1 Jindun Company Information
  45. 8.8.2 Jindun Business Overview
  46. 8.8.3 Jindun Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jindun Anti-inflammatory Medicine for Pets Product Portfolio
  48. 8.8.5 Jindun Recent Developments
  49. 8.9 Elanco
  50. 8.9.1 Elanco Company Information
  51. 8.9.2 Elanco Business Overview
  52. 8.9.3 Elanco Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Elanco Anti-inflammatory Medicine for Pets Product Portfolio
  54. 8.9.5 Elanco Recent Developments
  55. 8.10 Dechra Veterinary Products
  56. 8.10.1 Dechra Veterinary Products Company Information
  57. 8.10.2 Dechra Veterinary Products Business Overview
  58. 8.10.3 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Dechra Veterinary Products Anti-inflammatory Medicine for Pets Product Portfolio
  60. 8.10.5 Dechra Veterinary Products Recent Developments
  61. 8.11 Ceva
  62. 8.11.1 Ceva Company Information
  63. 8.11.2 Ceva Business Overview
  64. 8.11.3 Ceva Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Ceva Anti-inflammatory Medicine for Pets Product Portfolio
  66. 8.11.5 Ceva Recent Developments
  67. 8.12 CAHIC
  68. 8.12.1 CAHIC Company Information
  69. 8.12.2 CAHIC Business Overview
  70. 8.12.3 CAHIC Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 CAHIC Anti-inflammatory Medicine for Pets Product Portfolio
  72. 8.12.5 CAHIC Recent Developments
  73. 8.13 Boehringer Ingelheim
  74. 8.13.1 Boehringer Ingelheim Company Information
  75. 8.13.2 Boehringer Ingelheim Business Overview
  76. 8.13.3 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim Anti-inflammatory Medicine for Pets Product Portfolio
  78. 8.13.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Anti-inflammatory Medicine for Pets Value Chain Analysis
  2. 9.1.1 Anti-inflammatory Medicine for Pets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Anti-inflammatory Medicine for Pets Production Mode & Process
  6. 9.2 Anti-inflammatory Medicine for Pets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Anti-inflammatory Medicine for Pets Distributors
  9. 9.2.3 Anti-inflammatory Medicine for Pets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst